Statin drug industry generates OBSCENE PROFITS from institutional lies about cholesterol and the oversimplification of heart disease But today, doctors are indoctrinated and incentivized to push statin drugs on people at an early age, while ignoring all the dietary and lifestyle factors that influence heart disease risk.
The oversimplification of the causes of heart disease leads to widespread pill-pushing that benefits a statin drug industry that's built on a history of lies.
The pharmaceutical industry has long profited from the widespread belief that high cholesterol is a primary cause of heart disease.
In one study, COVID-19 outcomes are more severe for individuals with low cholesterol, suggesting that statin drugs cause immune-deficiencies that lead to worse outcomes for infectious disease.
The sugar industry, especially the high fructose corn syrup industry, is really at the heart of this controversy.
Internal documents reveal that the industry bribed scientists to downplay the link between sugar consumption and heart disease, shifting the blame onto saturated fat and cholesterol.
According to Data Bridge Market Research, the U.S. statin market size was valued at $4.53 billion in 2023 and is projected to reach $5.10 billion by 2031.
https://www.naturalnews.com/2024-08-27-statin-drug-industry-profits-from-lies-about-cholesterol.html
No comments:
Post a Comment